Innovia Medical acquires surgical instruments manufacturer DTR Medical

Innovia acquisition of DTR Medical : Medical devices manufacturer Innovia Medical has acquired Wales-based DTR Medical, which designs and manufactures single-use surgical instruments for general and specialist surgical procedures.

Financial terms of the deal were not disclosed.

Established in 2005, DTR Medical started selling its own-branded sterile single-use instruments. In 2007, the Swansea-based surgical instruments manufacturer launched its single-use gynaecology instruments range.

In 2012, DTR Medical launched its rotating cervical biopsy punch product and in the following year, launched the Clearway Suction Handle for foreign body removal. The surgical instruments manufacturer also offers cleanroom contract manufacturing services for a variety of pharmaceutical and medical device manufacturers.

Innovia Medical acquires surgical instruments manufacturer DTR Medical. Image courtesy of David Castillo Dominici at FreeDigitalPhotos.net.

Terry Meredith, CEO of Innovia Medical, commenting on Innovia acquisition of DTR Medical, said: “Since their founding in 2005, DTR Medical have established themselves as a multi-award winning manufacturer of quality and innovative single-use instruments. Exporting to over 30 countries they have built their reputation on consistently high product quality alongside their exceptional customer service.

“The strategic acquisition of DTR Medical will further strengthen Innovia’s global position in the ENT and Ophthalmic market; in addition, providing new opportunities in areas such as Gynaecology and General Surgery.”

The main products of DTR Medical are the Rotating Biopsy Punch, Frazier Suction Handle, Ear Specula, and Tibbs Arterial Cannula.

Commenting on Innovia acquisition of DTR Medical, Richard Salvage – Founder of DTR Medical, said: “The team at DTR Medical are dedicated to providing outstanding customer service, alongside high quality products that deliver clinical value and improved patient outcomes. It was important for us to find a partner who shared and respected the same core values, whilst providing the opportunity to take our vision to new markets.”